Company Filing History:
Years Active: 2025
Title: Florian Salopiata: Innovator in Peptide-MHC Binding Characterization
Introduction
Florian Salopiata is a notable inventor based in Tuebingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the characterization of peptide-MHC binding polypeptides. His work is essential for advancements in immunology and therapeutic development.
Latest Patents
Florian holds a patent titled "Method for the Characterization of Peptide:MHC Binding Polypeptides." This patent represents his innovative approach to understanding the interactions between peptides and major histocompatibility complex (MHC) molecules, which is crucial for immune response research. He has 1 patent to his name.
Career Highlights
Florian is currently employed at Immatics Biotechnologies GmbH, a company that focuses on developing innovative cancer immunotherapies. His role at Immatics allows him to apply his expertise in peptide-MHC interactions to real-world applications, contributing to the advancement of cancer treatment options.
Collaborations
Florian collaborates with talented colleagues, including Heiko Schuster and Meike Hutt. Their combined efforts enhance the research and development capabilities at Immatics, fostering a collaborative environment that drives innovation.
Conclusion
Florian Salopiata is a key figure in the field of biotechnology, with a focus on peptide-MHC binding characterization. His contributions through patents and collaboration with colleagues position him as an influential inventor in the industry.